Our work uncovered that CHOP and R-CHOP treatment increased the proportions of DCs and M1 macrophages, and decreased the proportion of M2 macrophages in DLBCL-bearing mice. The gene discussed is DDIT3; the disease is diffuse large B-cell lymphoma.